Novadiscovery knowledge-driven models virtual patients in-silico clinical trials de-risk optimize Drug R&D
Location: France, Auvergne-Rhône-Alpes, Lyon
Employees: 11-50
Founded date: 2010
Investors 1
| Date | Name | Website |
| - | Debiopharm | debiopharm... |
Mentions in press and media 7
| Date | Title | Description |
| 11.01.2023 | In Silico: From Knowledge Curation to Clinical Trial Simulation, Upcoming Webinar Hosted by Xtalks | When embarking on a new R&D program, scientists face a strategic imperative to assemble the best and most relevant available data and insights. TORONTO (PRWEB) January 11, 2023 These past few years have marked the acceleration of the ad... |
| 14.04.2022 | In silico Clinical Trials with Virtual Populations Help Accelerate Access to New Drugs, Upcoming Webinar Hosted by Xtalks | In silico approaches are critical as medicines become more personalized and conventional trials become more challenging, both practically and ethically. TORONTO (PRWEB) April 14, 2022 In silico modeling enhances clinical trials. Unlike regu... |
| 16.12.2021 | Novadiscovery expands Janssen collaboration by implementing its JINKO® clinical trial simulation platform for the development of lung cancer models | Novadiscovery expands Janssen collaboration by implementing its JINKO® clinical trial simulation platform for the development of lung cancer models Janssen intends to use computational disease models to investigate benefits of in silico tri... |
| 02.11.2021 | Novadiscovery Continues Global Expansion with the Launch of its US Headquarters in Boston, MA | Novadiscovery Continues Global Expansion with the Launch of its US Headquarters in Boston, MA The new office will support continued expansion into the US market, NOVA’s largest customer base, and provide customers with access to NOVA’s coll... |
| 22.07.2021 | Novadiscovery appoints Grégoire Boutonnet as Chief Operating Officer | Novadiscovery appoints Grégoire Boutonnet as Chief Operating Officer Appointment of Grégoire supports NOVA’s continued international expansion Lyon, France – 22 July 2021: Novadiscovery (NOVA), a leading health tech company using in silico ... |
| 26.03.2021 | Novadiscovery announces new clinical simulation collaboration with Takeda | Novadiscovery announces new clinical simulation collaboration with Takeda Lyon, France – 26 March, 2021 Novadiscovery (“NOVA”), a leading health tech company offering JINKO, a best-in-class clinical trial simulation platform to predict drug... |
| 16.02.2021 | Novadiscovery raises Series A2 financing from Sanofi to advance JINKO, its best-in-class clinical trial simulation platform | Novadiscovery raises Series A2 financing from Sanofi to advance JINKO, its best-in-class clinical trial simulation platform NOVA to develop COVID-19 disease model to support Sanofi’s vaccine and therapeutic efforts Lyon, France – 16 Februar... |